| Identification | Back Directory | [Name]
Posatirelin | [CAS]
78664-73-0 | [Synonyms]
RGH-2202
Posatirelin
N-[(S)-6-Oxo-2-piperidinylcarbonyl]-L-Leu-L-Pro-NH2
N-[6-Oxopiperidin-2(S)-Ylcarbonyl]-L-Leucyl-L- Prolinamide | [Molecular Formula]
C17H28N4O4 | [MDL Number]
MFCD00865152 | [MOL File]
78664-73-0.mol | [Molecular Weight]
352.43 |
| Questions And Answer | Back Directory | [Pharmacological Study]
Posatirelin is a TRH analogue. In a rat experimental model
of brain cholinergic deficit by lesion of the nucleus basalis
magnocellularis (nbM), posatirelin treatment rescued
cholinergic neurones of the nbM and their cholinergic
projections to the cerebral cortex (Sabbatini et al., 1998).
Posatirelin has been used in AD and VaD patients (Parnetti
et al., 1995, 1996). VaD patients treated with posatirelin
showed a significant improvement in intellectual performance,
orientation, motivation and memory as compared
to controls. The drug was well tolerated. |
| Hazard Information | Back Directory | [Description]
Posatirelin is a TRH analogue. In a rat experimental model of brain cholinergic decit by lesion of the nucleus basalis magnocellularis (nbM), posatirelin treatment rescued cholinergic neurones of the nbM and their cholinergic projections to the cerebral cortex (Sabbatini et al., 1998). Posatirelin has been used in AD and VaD patients (Parnetti et al., 1995, 1996). VaD patients treated with posatirelin showed a signicant improvement in intellectual performance, orientation, motivation and memory as compared to controls. e drug was well tolerated. | [Uses]
Posatirelin is a thyrotropin-releasing hormone analogue, used in the treatment of seizures and some neurodegenerative disease such as vascular dementia and Parkinson''s disease. | [Definition]
ChEBI: Posatirelin is an oligopeptide. |
|
|